503. Clonal Hematopoiesis, Aging, and Inflammation: Poster I

A Senescent Subset in Human Hematopoietic Stem Cell (HSC) Compartment As Target for Senotherapy

Associations of Lineage-Specific Clonal Hematopoiesis with COVID-19 Hospitalization and Mortality

DNMT3A-Mutant Clonal Haematopoiesis Is Associated with Worse Recovery after ST-Elevation Myocardial Infarction Via Increased Inflammation

Dnmt3a Mutant Hematopoietic Stem Cells Produce Hyperactive T Cells with Increased Alloimmune and Anti-Leukemic Activity

Emergence of DNA Damage Repair Clonal Hematopoiesis after Peptide Receptor Radionuclide Therapy for Neuroendocrine Tumors

Inflammatory Reprogramming of the Tumor Microenvironment By Clonal Hematopoiesis Is Associated with Clinical Outcomes in Solid Cancer

Mapping Genotype to Phenotype in Clonal Hematopoiesis Uncovers Downregulated MHC-II Molecules in DNMT3AR882 - Mutant Hematopoietic Stem Cells

Predictive Modeling of Clonal Hematopoiesis across Diverse Cohorts

Statin Therapy Is Associated with Reduced Clonal Expansion in TET2 Mutated Clonal Haematopoiesis of Indeterminate Potential

The Effect of TET2 Loss on Macrophage Phagocytosis

iPSC Reprogramming Identifies the Role of Cryptic Drivers in Preleukemic Clonal Evolution